ArticlePloS one2013

An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.

Lawren VandeVrede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.